Anika Therapeutics, Inc. – NASDAQ:ANIK
Anika Therapeutics stock price today
$8.59
-7.64
-47.11%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market open
Closed in about 4 hours
Anika Therapeutics stock price monthly change
-40.14%
month
Anika Therapeutics stock price quarterly change
-40.14%
quarter
Anika Therapeutics stock price yearly change
-28.43%
year
Anika Therapeutics key metrics
Market Cap | 238.57M |
Enterprise value | 347.61M |
P/E | -26.87 |
EV/Sales | 2.22 |
EV/EBITDA | -96.42 |
Price/Sales | 2.57 |
Price/Book | 1.41 |
PEG ratio | 0.05 |
EPS | -5.25 |
Revenue | 169.26M |
EBITDA | -8.21M |
Income | -76.83M |
Revenue Q/Q | 6.85% |
Revenue Y/Y | 7.48% |
Profit margin | -9.51% |
Oper. margin | -12.42% |
Gross margin | 59.89% |
EBIT margin | -12.42% |
EBITDA margin | -4.86% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAnika Therapeutics stock price history
Anika Therapeutics stock forecast
Anika Therapeutics financial statements
| Jun 2023 | 44.30M | -2.74M | -6.19% |
|---|---|---|---|
| Sep 2023 | 41.46M | -6.57M | -15.86% |
| Dec 2023 | 42.97M | -63M | -146.61% |
| Mar 2024 | 40.52M | -4.51M | -11.14% |
| Mar 2024 | 40.52M | -4.51M | -11.14% |
|---|---|---|---|
| Sep 2025 | 45.6M | 3.07M | 6.75% |
| Oct 2025 | 45.93M | 3.42M | 7.47% |
| Dec 2025 | 49.06M | 5.04M | 10.28% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 328882000 | 54.86M | 16.68% |
|---|---|---|---|
| Sep 2023 | 328158000 | 57.67M | 17.57% |
| Dec 2023 | 270632000 | 58.36M | 21.57% |
| Mar 2024 | 263744000 | 55.20M | 20.93% |
| Jun 2023 | -8.29M | -1.45M | -4.94M |
|---|---|---|---|
| Sep 2023 | 6.48M | -741K | -110K |
| Dec 2023 | 3.63M | -1.84M | 342K |
| Mar 2024 | -126K | -1.80M | -2.27M |
Anika Therapeutics alternative data
| Sep 2023 | 345 |
|---|---|
| Oct 2023 | 345 |
| Nov 2023 | 345 |
| Dec 2023 | 345 |
| Jan 2024 | 345 |
| Feb 2024 | 345 |
| Mar 2024 | 357 |
| Apr 2024 | 357 |
| May 2024 | 357 |
| Jun 2024 | 357 |
| Jul 2024 | 357 |
Anika Therapeutics other data
49.96%
-39.78%
of ANIK is owned by hedge funds
78
-44
7.27M
-5.82M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Aug 2021 | 3627 | 0 |
| Mar 2022 | 15600 | 0 |
| May 2022 | 1500 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Option | BLANCHARD CHERYL R director, officer.. | Common Stock | 30,059 | N/A | N/A | ||
Option | BLANCHARD CHERYL R director, officer.. | Common Stock | 20,001 | N/A | N/A | ||
Option | BLANCHARD CHERYL R director, officer.. | Common Stock | 14,420 | N/A | N/A | ||
Option | BLANCHARD CHERYL R director, officer.. | Restricted Stock Unit | 20,001 | N/A | N/A | ||
Option | BLANCHARD CHERYL R director, officer.. | Restricted Stock Unit | 30,059 | N/A | N/A | ||
Option | BLANCHARD CHERYL R director, officer.. | Restricted Stock Unit | 14,420 | N/A | N/A | ||
Option | COLLERAN DAVID officer: EVP, Gen.. | Common Stock | 7,662 | N/A | N/A | ||
Option | COLLERAN DAVID officer: EVP, Gen.. | Common Stock | 5,465 | N/A | N/A | ||
Option | COLLERAN DAVID officer: EVP, Gen.. | Common Stock | 3,682 | N/A | N/A | ||
Option | COLLERAN DAVID officer: EVP, Gen.. | Restricted Stock Unit | 5,465 | N/A | N/A |
| Patent |
|---|
Application Filling date: 24 Jun 2021 Issue date: 30 Dec 2021 |
Application Filling date: 14 Oct 2020 Issue date: 9 Sep 2021 |
Application Filling date: 26 Aug 2020 Issue date: 15 Jul 2021 |
| Quarter | Transcript |
|---|---|
| Q1 2024 8 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 13 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 3 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 8 Aug 2023 | Q2 2023 Earnings Call Transcript |
-
What's the price of Anika Therapeutics stock today?
One share of Anika Therapeutics stock can currently be purchased for approximately $8.59.
-
When is Anika Therapeutics's next earnings date?
Unfortunately, Anika Therapeutics's (ANIK) next earnings date is currently unknown.
-
Does Anika Therapeutics pay dividends?
No, Anika Therapeutics does not pay dividends.
-
How much money does Anika Therapeutics make?
Anika Therapeutics has a market capitalization of 238.57M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 6.67% to 166.66M US dollars.
-
What is Anika Therapeutics's stock symbol?
Anika Therapeutics, Inc. is traded on the NASDAQ under the ticker symbol "ANIK".
-
What is Anika Therapeutics's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Anika Therapeutics?
Shares of Anika Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Anika Therapeutics's key executives?
Anika Therapeutics's management team includes the following people:
- Dr. Cheryl Renee Blanchard Ph.D. Pres, Chief Executive Officer & Director(age: 61, pay: $1,100,000)
- Mr. David Colleran Executive Vice President, Gen. Counsel & Corporation Sec.(age: 53, pay: $579,220)
- Mr. James Loerop Executive Vice President of Bus. Devel. & Strategic Planning(age: 61, pay: $575,420)
- Mr. Michael L. Levitz Executive Vice President, Chief Financial Officer & Treasurer(age: 51, pay: $525,920)
- Mr. Thomas M. Finnerty Executive Vice President of HR(age: 67, pay: $517,420)
-
How many employees does Anika Therapeutics have?
As Jul 2024, Anika Therapeutics employs 357 workers.
-
When Anika Therapeutics went public?
Anika Therapeutics, Inc. is publicly traded company for more then 32 years since IPO on 3 May 1993.
-
What is Anika Therapeutics's official website?
The official website for Anika Therapeutics is anikatherapeutics.com.
-
Where are Anika Therapeutics's headquarters?
Anika Therapeutics is headquartered at 32 Wiggins Avenue, Bedford, MA.
-
How can i contact Anika Therapeutics?
Anika Therapeutics's mailing address is 32 Wiggins Avenue, Bedford, MA and company can be reached via phone at +7 814579000.
Anika Therapeutics company profile:
Anika Therapeutics, Inc.
anikatherapeutics.comExchange:
NASDAQ
Full time employees:
357
Industry:
Medical - Devices
Sector:
Healthcare
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management product family consists of Monovisc, Orthovisc, Cingal, and Hyvisc that are indicated to provide pain relief from osteoarthritis conditions; and joint preservation and restoration product family comprise a portfolio of approximately 150 bone preserving joint technology products, a line of sports medicine soft tissue repair solutions, and orthopedic regenerative solutions products. The company's non-orthopedic product family include HA-based products for non-orthopedic applications, including adhesion barrier products, advanced wound care products, ophthalmic products, and ear, nose, and throat products. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.
32 Wiggins Avenue
Bedford, MA 01730
Bedford, MA 01730
CIK: 0000898437
ISIN: US0352551081
CUSIP: 035255108
